Chinese Regulators Move Forward on IND Review

International Pharmaceutical Regulatory Monitor
A A
China’s FDA has issued guidance on a formal investigational new drug review process that is expected to speed up approvals.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor